MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
Imported from official source
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)
This version
- Version
- 1 of 1
- Recorded
- October 19, 2026 16:01
- Change
- Initial
- Content hash
fc82ef35ca2a31d29de57ec191e8a8b6- All versions
- Revision history